Nordic Science Investments

Vision ➨ Reality in just 2 years This year at SLUSH, we experienced the profound impact our technology can have on real people, with real stories. This has always been our mission, and now we see it coming to fruition. SLUSH has always been a fantastic platform for connecting the ecosystem, sharing knowledge, and collaboration. However, this year meant so much more for us. Through a technical demonstration of carotid artery screening, we showed how our technology can detect cardiovascular issues that might otherwise go unnoticed, validating just how important this work is. The tangible impact of our work was highlighted during our CEO Jack's presentation on the Startup Stage. He emphasised our broader mission: to automate cardiovascular analysis and exponentiate productivity, ultimately expanding access to preventative screening. This approach enables us to identify diseases long before they become critical. On behalf of the whole team, we'd like to extend our deepest gratitude to: • Tiina Ketonen and Pihlajalinna for expert clinical oversight  • The whole team at Maria 01 for hosting us, and Sarita Runeberg for spreading the word! • The Nordic Science Investments team for their insights and support so far. We're already impacting lives! • Slush for providing an exceptional platform for innovation, special mention to Maryama Moalim • Every participant who took part in the demonstration - you have helped advance the future of AI-powered prevention If you're concerned about your cardiovascular risk or want to learn more about our technology, please reach out.

🚀 We love Y Science! 🚀 Our partner Alexandra Gylfe PhD delivered an inspiring talk at Slush Y Science on "Research Commercialization Through VC Collaboration" to a packed house of 1,000+ attendees. Here are the highlights: 1️⃣ A Strong Foundation for Spinouts: University spinouts in Finland make up 20% of the top ten recent biggest exits. In general, only 10% of university spinouts fail within their first five years, proving they are far less risky than generally presumed. 2️⃣ Bridging Worlds: As a former researcher and biotech executive, Alexandra shared her journey from cancer research to venture capital, highlighting the critical need for stronger collaboration between VCs and university researchers to unlock the full potential of commercialization projects. 3️⃣ AI in Action: AI is reshaping life sciences and deep tech by dramatically accelerating innovation, driving breakthroughs in areas like disease detection, diagnosis, and complex data analysis. Alexandra highlighted AIATELLA, an NSI portfolio company, which conducted AI-powered vascular screenings for hundreds of Slush participants at their booth, providing instant insights into cardiovascular health. 💫 A big thank you to Orion Corporation, University of Helsinki and Helsinki Innovation Services Ltd for the invitation and for organizing such an inspiring event! #SlushYScience #NordicResearch #DeepTech #Spinout

Nordic Science Investments (NSI) was established to address a crucial funding gap for seed-stage startups. In March 2024, NSI reached an important milestone with the first close of its inaugural venture capital fund, targeting a total of EUR 80 million with Tesi as one of its investors. 📈 This autumn, we published a case article highlighting NSI’s mission and approach. 🖊️ Now, you can read the article through the link and watch a short video reel below. 🎥👇 https://lnkd.in/dU5DBMtv #VentureCapital #Commercialisation #TechTransfer #Universities #Innovations Alexandra Gylfe PhD, Anssi Uimonen, Jari Strandman, Matti Hautsalo P.s. We publised our deep tech in Finland study 2024 yesterday! Take a look behind the link below: https://lnkd.in/g4ZJNhvz

NSI team is growing - thrilled to welcome Mart Maasik to Nordic Science Investments as a partner! 👏 With his strong background in launching and leading the University of Tartu’s asset management company and co-founding SEB’s Innovation Lab, Mart brings invaluable expertise to NSI. With Mart on board, NSI - the first specialized VC fund for science-based spinouts in the Nordics and Baltics - is further strengthening its commitment to supporting Estonian scientists and innovators. Together, we’re building a powerful community across the New Nordics - Estonia, Finland, Sweden, and beyond - to position our region as a frontrunner in research commercialisation. Warm welcome Mart Maasik! 🌟 #deeptech #spinout #VC

Nordic Science Investments has led the seed round of PrecisionPhage Ltd, a recent spinout from the University of Jyväskylä at the forefront of combating antibiotic-resistant superbugs. By analyzing phage genomes, the company enhances the safety and effectiveness of phage therapy, offering highly targeted treatments for bacterial infections. With one of the world’s largest phage collections, PrecisionPhage is driving innovation in bioinformatics, laboratory services, and phage licensing to tackle the global challenge of antibiotic resistance. There has already been significant interest in the dual-use potential of its technology, especially for biodefense and bioterrorism prevention. Welcome to our portfolio PrecisionPhage Ltd Matti Jalasvuori Liisa Chisty, PhD Ville Hoikkala Saija Kiljunen 💫 #deeptech #spinout

Check out Nordic Science Investments portfolio on our brand-new webpage! We invest in deeptech, healthtech, and life sciences - sectors where innovation can drive significant impact. 💫 #deeptech #commercialisation #impact #investing

Nordic Science Investments (NSI) was founded to bridge a funding gap for seed-stage startups. In March 2024, NSI successfully made the first closing of its first venture capital fund, aiming for a total size of EUR 80 million. By leveraging their expertise, the NSI team helps university research teams turn their groundbreaking inventions into commercial success stories. 💶📈 Discover more about the NSI team and the strategy behind their new fund in our case article! 👇 https://lnkd.in/dU5DBMtv #VentureCapital #SeedFunding #UniversityInnovations #Startups

Nordic Science Investments is happy to take part and support the upcoming Slush side event “New Nordics HealthTech Matchmaking”! A Slush ticket is not required. Sign up in the link 👇. Hope to see many of you there! 💫 #universityspinout #innovation #healthtech #deeptech

🙌 Innovation thrives when the right innovators meet the right investors. Excited to introduce our investor partners Alexandra Gylfe PhD and Matti Hautsalo, both founding Partners at Nordic Science Investments. (Health Design pitching competition DL is on 29th of September. Send your application today, link in the comments) ✨ Nordic Science Investments sees university research as the most promising source for disruptive innovations and breakthrough technologies. 🔬 According to research, investing in science-based startups is not as risky as it’s widely believed: Fewer than 10% of university spinouts fail within their first five years. Join Health Design today and meet Alexandra Gylfe PhD and Matti Hautsalo on 15th-16th of October. Our pitching competition DL is on 29th of September. Send your application today, link in the comments. Please repost this if you have promising medtech, digital health and lifescience/pharma startups in your network. Health Incubator Helsinki, Terveysteknologia ry - Healthtech Finland, Aalto Startup Center, Terkko Health Hub, Kuopio Health, Health Founders, SPARK Finland, University of Oulu, Business Turku, Business Tampere, Kuopio Health, Enter Espoo, Maria 01, Finnish Business Angels Network (FiBAN), Innovestor, Tesi, Athensmed, Hopohopo.io, Loora Salurand, Priit Kruus, Pernille Kølbæk, Prateek Singh, Lasse Leppäkorpi, Sakari Soini, Milapsinh Jadeja,

Great discussions on the potential of science-based spinouts and shifting investor attitudes towards deep tech at NORDEEP Summit! 💫